Adviser Research Centre Webinar: Best Stock Ideas March 2023

A round up of notable stories and reactions as ASX earnings season continues.

Our healthcare analyst Shane Ponraj helps me compare the moatiness and growth prospects of two sector heavyweights.

Simplification plan complete, organic growth now the focus.

Cost containment and growing revenue bode well for profit margins.

Sales growth at CSL was lower than expected but streamlining the business has its perks.

Results were softer than expected.